Dr Reddy's Archives - Equitypandit

Sensex Sinks 637 Points, Gives Up 61,00, Nifty Near 18,000, Realty, Metals Lead Losses

NileshJanuary 4, 2023

by NileshJanuary 4, 202301631

Stocks fell under selling pressure on Wednesday, snapping a two-day winning streak, as Wall Street awaited the release of minutes from the latest Federal Reserve...

STOCK MARKET

Sensex And Nifty50 Widen Their Gap on Back of Financials, IT And FMCG Stocks

NileshSeptember 8, 2022September 8, 2022

by NileshSeptember 8, 2022September 8, 202202260

India’s stock market benchmark rose for the first time on Thursday after it began tracking strength in global markets, as investors ignored price pressures cited...

HEALTHCARE

Dr Reddy’s Lowers Price of Sputnik Booster

NileshMay 19, 2022May 19, 2022

by NileshMay 19, 2022May 19, 202201233

Dr Reddy’s lab said on May 19 that it would reduce the price of the Sputnik Light vaccine, which will be used as a booster...

Latest News

Dr Reddy’s gets EIR for Medak units from USFDA

adminJune 28, 2018

by adminJune 28, 201801000

Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR) for the company’s Medak units, from the US health regulator. The company stated the exchanges that, it has...

Latest News

Dr Reddy’s Q4 net profit down 3.3% YoY

adminMay 22, 2018

by adminMay 22, 20180861

Dr Reddy’s Laboratories net profit slumps 3.3% YoY to Rs.302.2 crore, for the quarter ended March 31,2018. The company in the same quarter last year,...

Latest News

Dr Reddy’s launches Palonosetron Hydrochloride Injection in US

adminMarch 26, 2018

by adminMarch 26, 20180723

Dr Reddy’s Laboratories Limited has launched Palonosetron Hydrochloride Injection, 0.25 mg/ml in US. It has been approved by the US Food and Drug Administration (USFDA) and...

Latest News

Dr Reddy’s receives USFDA approval for Sapropterin Dihydrochloride

adminDecember 28, 2017

by adminDecember 28, 20170908

Dr Reddy’s Laboratories has received approval from the US health regulator for drug that reduces blood phenylalanine concentrations in patients. It has received tentative approval from...

Latest News

Dr Reddy’s receives EIR for Bachupally unit from USFDA

adminDecember 12, 2017

by adminDecember 12, 201701007

Dr Reddy’s Laboratories has received an establishment inspection report (EIR) for Bachupally unit, Hyderabad, after the closure of its audit from the US Food and Drug...

Latest News

Dr Reddy’s receives EIR for Telangana unit, from USFDA

adminDecember 4, 2017

by adminDecember 4, 20170977

Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR), for its Miyapur facility, Hyderabad, Telangana. The Custom Pharmaceutical Services facility, of Dr Reddy’s Laboratories at the...

Latest News

Dr Reddy’s receives first cycle approval for psoriasis treatment

adminDecember 1, 2017

by adminDecember 1, 20170846

Dr Reddy’s Laboratories has received first cycle new drug application (NDA) approval, from the US health regulator, for its Impoyz cream used for treating psoriasis....

Download Unicorn Signals App

EquityPandit

Tag : Dr Reddy’s

Sensex Sinks 637 Points, Gives Up 61,00, Nifty Near 18,000, Realty, Metals Lead Losses

Sensex And Nifty50 Widen Their Gap on Back of Financials, IT And FMCG Stocks

Dr Reddy’s Lowers Price of Sputnik Booster

Dr Reddy’s gets EIR for Medak units from USFDA

Dr Reddy’s Q4 net profit down 3.3% YoY

Dr Reddy’s launches Palonosetron Hydrochloride Injection in US

Dr Reddy’s receives USFDA approval for Sapropterin Dihydrochloride

Dr Reddy’s receives EIR for Bachupally unit from USFDA

Dr Reddy’s receives EIR for Telangana unit, from USFDA

Dr Reddy’s receives first cycle approval for psoriasis treatment

EquityPandit